Sign Out
Human experience of overdose with abiraterone acetate (Zytiga) is limited.
There is no specific antidote. In the event of an overdose, administration should be withheld and general supportive measures undertaken, including monitoring for arrhythmias, hypokalemia and for signs and symptoms of fluid retention. Liver function also should be assessed.
